Scannevin R, Alexander R, Haarlander T, Burke S, Singer M, Huo C, et al. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation. J Biol Chem. 2017;292:17963-17974 pubmed publisher

Duellman T, Warren C, Yang J. Single nucleotide polymorphism-specific regulation of matrix metalloproteinase-9 by multiple miRNAs targeting the coding exon. Nucleic Acids Res. 2014;42:5518-31 pubmed publisher

Aujla P, Huntley G. Early postnatal expression and localization of matrix metalloproteinases-2 and -9 during establishment of rat hippocampal synaptic circuitry. J Comp Neurol. 2014;522:1249-63 pubmed publisher

Cayabyab F, Gowribai K, Walz W. Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity. J Neurosci Res. 2013;91:920-33 pubmed publisher

Deniro M, Al Mohanna F, Alsmadi O, Al Mohanna F. The nexus between VEGF and NF?B orchestrates a hypoxia-independent neovasculogenesis. PLoS ONE. 2013;8:e59021 pubmed publisher

Duellman T, Warren C, Peissig P, Wynn M, Yang J. Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm. Circ Cardiovasc Genet. 2012;5:529-37 pubmed publisher

Delfin D, Zang K, Schill K, Patel N, Janssen P, Raman S, et al. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases. Neuromuscul Disord. 2012;22:1006-14 pubmed publisher

Moore B, Manthey C, Johnson D, Bauer A. Matrix metalloproteinase-9 inhibition reduces inflammation and improves motility in murine models of postoperative ileus. Gastroenterology. 2011;141:1283-92, 1292.e1-4 pubmed publisher

DeNiro M, Al Halafi A, Al Mohanna F, Alsmadi O, Al Mohanna F. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol Pharmacol. 2010;77:348-67 pubmed publisher